IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
39 hedge funds and large institutions have $73.9M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+3
Holders Change %
+8.33%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
4
Increased
11
Reduced
10
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
$1.24M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
$723K |
| 3 |
DA
DCF Advisers
Greenwich,
Connecticut
|
$2.29M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$64K |
| 5 |
BlackRock
New York
|
$523K |
Top Sellers
| 1 |
Millennium Management
New York
|
$155K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$333K |
| 3 |
Morgan Stanley
New York
|
$55K |
| 4 |
E
Ergoteles
New York
|
$119K |
| 5 |
Goldman Sachs
New York
|
$55K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $50K | +$44.1K | +9,035 | +747% |
|
|
LC
27
Lindbrook Capital
Calabasas,
California
| $15K | – | – | – |
|
28
BNP Paribas Financial Markets
Paris,
France
| $6.67K | +$6.67K | +1,369 | New |
|
29
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
30
JPMorgan Chase & Co
New York
| $6K | +$1.4K | +309 | +31% |
|
31
Osaic Holdings
Scottsdale,
Arizona
| $3K | – | – | – |
|
32
Citigroup
New York
| $2K | -$348 | -60 | -15% |
|
33
Bank of America
Charlotte,
North Carolina
| $1K | -$1.51K | -315 | -60% |
|
|
CUAMC
34
China Universal Asset Management Company
Shanghai,
China
| $1K | +$1K | +223 | New |
|